Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	18676
Country	South Korea

Received	2015-04-27 14:18
Peer-Review Started	2015-04-27 18:32
To Make the First Decision	2015-07-17 17:51
Return for Revision	2015-07-25 15:16
Revised	2015-08-01 21:31
Second Decision	2015-09-02 15:42
Accepted by Journal Editor-in-Chief	2015-09-02 22:36
Accepted by Company Editor-in-Chief	2015-09-28 17:44
Articles in Press	2015-09-28 17:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-19 17:32
Publish the Manuscript Online	2015-11-12 18:51

ISSN	2150-5349 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Antibiotic treatment for Helicobacter pylori: Is the end coming?
Manuscript Source	Invited Manuscript
All Author List	Su Young Kim, Duck Joo Choi and Jun-Won Chung
Funding Agency and Grant Number
Corresponding Author	Jun-Won Chung, MD, PhD, Division of Gastroenterology, Department of Internal Medicine, Gachon University, Gil Medical Center, 21, Namdong-daero 774 beon-gil, Namdong-gu, Incheon 405-760, South Korea. junwonchung@daum.net
Key Words	Helicobacter pylori; Treatment; Antibiotic resistance; Therapeutic regimens; Novel agents
Core Tip	This article reviews the recent literature describing antibiotic resistance and trends in Helicobacter pylori (H. pylori) treatment. As there is no effective conventional therapy, new treatments are being developed and bismuth quadruple, sequential, concomitant therapies are recommended as a first-line regimen in regions with high levels of clarithromycin resistance. Quinolones have also been used for H. pylori treatment, although the cure rate has gradually reduced with this approach. New therapeutic directions include probiotic supplementation, tailored therapy, novel agents, and nanotechnology.
Publish Date	2015-11-12 18:51
Citation	Kim SY, Choi DJ, Chung JW. Antibiotic treatment for Helicobacter pylori: Is the end coming? World J Gastrointest Pharmacol Ther 2015; 6(4): 183-198
URL	http://www.wjgnet.com/2150-5349/full/v6/i4/183.htm
DOI	http://dx.doi.org/10.4292/wjgpt.v6.i4.183

Full Article (PDF)	WJGPT-6-183.pdf
Full Article (Word)	WJGPT-6-183.doc
Manuscript File	18676-Review.docx
Answering Reviewers	18676-Answering reviewers.pdf
Audio Core Tip	18676-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18676-Conflict-of-interest statement.PDF
Copyright License Agreement	18676-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate	18676-Language certificate.pdf
Peer-review Report	18676-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	18676-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	18676-Scientific misconduct check.pdf
Scientific Editor Work List	18676-Scientific editor work list.pdf